Our study suggests that methylpheni date retains its efficacy in children with ADHD and borderline intellectual functioning or ID
Attention-deficit/hyperactivity disorder ( ADHD ) frequently co-occurs with intellectual disability in children , and may further compromise learning .
Methylpheni date is a first-line treatment for ADHD , however no previous meta- analysis has evaluated its overall efficacy for ADHD in children with comorbid intellectual disability ( ID ) or borderline intellectual functioning .
A controlled trial of stimulant medication in children with the fragile X syndrome.
Attentional deficits and hyperactivity frequently are major problems for fra(X ) boys . This study evaluated the effectiveness of 2 stimulant medications , methylpheni date and dextroamphetamine compared to placebo in 15 children ( 13 males , 2 females ) with the fra(X ) syndrome . A double-blind crossover design was used with outcome measures which included parent and teacher behavior checklists , a controlled observation period , continuous performance tasks and an actometer measure of movement . When the children were treated with methylpheni date only , improvement was seen in socialization skills and attention span according to teacher checklists .  Ten children were clinical ly considered responders and treatment was continued after the study was completed
Our study suggests that methylpheni date retains its efficacy in children with ADHD and borderline intellectual functioning or ID
Attention-deficit/hyperactivity disorder ( ADHD ) frequently co-occurs with intellectual disability in children , and may further compromise learning .
Methylpheni date is a first-line treatment for ADHD , however no previous meta- analysis has evaluated its overall efficacy for ADHD in children with comorbid intellectual disability ( ID ) or borderline intellectual functioning .